Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lubov Timchenko

Showing results (21-30 of 43) with videos related to

Pageof 5
Sort By:
Journal of Biomolecular NMR|March 10, 2005
(1)H, (15)N and (13)C chemical shift assignments of RNA repeats binding protein -- CUGBP1abKyu-Yeon Jun, Youlin Xia, Xiaogang Han, et al.
Human Molecular Genetics|January 14, 2025
The role of CNBP in brain atrophy and its targeting in myotonic dystrophy type 2Katherine Jennings, Diana Lindquist, Ankita Poonia, et al.
The Journal of Biological Chemistry|November 26, 2013
Age-associated change of C/EBP family proteins causes severe liver injury and acceleration of liver proliferation after CCl4 treatmentsIl-Hwa Hong, Kyle Lewis, Polina Iakova, et al.
Cancers|December 23, 2022
Phosphorylation-Mediated Activation of β-Catenin-TCF4-CEGRs/ALCDs Pathway Is an Essential Event in Development of Aggressive HepatoblastomaRuhi Gulati, Margaret A Hanlon, Maggie Lutz, et al.
Cancers|March 28, 2026
Fusion <i>DNAJB1::PRKACA</i> in Non-Fibrolamellar Cancer Cases. Reply to Arif et al. Global Re-Analysis Confirms Absence of the <i>DNAJB1::PRKACA</i> Fusion in Hepatoblastoma. Comment on "Fleifil et al. DNAJB1-PKAc Kinase Is Expressed in Young Patients with Pediatric Liver Cancers and Enhances Carcinogenic Pathways. <i>Cancers</i> 2025, <i>17</i>, 83"Yasmeen Fleifil, Ruhi Gulati, Katherine Jennings, et al.
Molecular and Cellular Biology|August 7, 2019
Correction of Glycogen Synthase Kinase 3β in Myotonic Dystrophy 1 Reduces the Mutant RNA and Improves Postnatal Survival of DMSXL MiceMei Wang, Wen-Chin Weng, Lauren Stock, et al.
International Journal of Molecular Sciences|November 13, 2025
Elevated Levels of Active GSK3β in the Blood of Patients with Myotonic Dystrophy Type 1 Correlate with Muscle WeaknessKatherine Jennings, Cuixia Tian, Rebeccah L Brown, et al.
The EMBO Journal|January 17, 2004
Competition of CUGBP1 and calreticulin for the regulation of p21 translation determines cell fatePolina Iakova, Guo-Li Wang, Lubov Timchenko, et al.
The Journal of Biological Chemistry|April 9, 2013
Transcriptional and translational regulation of C/EBPβ-HDAC1 protein complexes controls different levels of p53, SIRT1, and PGC1α proteins at the early and late stages of liver cancerJingling Jin, Polina Iakova, Yanjun Jiang, et al.
Molecular and Cellular Biology|June 1, 2017
RNA Binding Protein CUGBP1 Inhibits Liver Cancer in a Phosphorylation-Dependent MannerKyle Lewis, Leila Valanejad, Ashley Cast, et al.
Pageof 5

Showing results (21-30 of 43) with videos related to

Sort By:
Pageof 5
Journal of Biomolecular NMR|March 10, 2005
(1)H, (15)N and (13)C chemical shift assignments of RNA repeats binding protein -- CUGBP1abKyu-Yeon Jun, Youlin Xia, Xiaogang Han, et al.
Human Molecular Genetics|January 14, 2025
The role of CNBP in brain atrophy and its targeting in myotonic dystrophy type 2Katherine Jennings, Diana Lindquist, Ankita Poonia, et al.
The Journal of Biological Chemistry|November 26, 2013
Age-associated change of C/EBP family proteins causes severe liver injury and acceleration of liver proliferation after CCl4 treatmentsIl-Hwa Hong, Kyle Lewis, Polina Iakova, et al.
Cancers|December 23, 2022
Phosphorylation-Mediated Activation of β-Catenin-TCF4-CEGRs/ALCDs Pathway Is an Essential Event in Development of Aggressive HepatoblastomaRuhi Gulati, Margaret A Hanlon, Maggie Lutz, et al.
Cancers|March 28, 2026
Fusion <i>DNAJB1::PRKACA</i> in Non-Fibrolamellar Cancer Cases. Reply to Arif et al. Global Re-Analysis Confirms Absence of the <i>DNAJB1::PRKACA</i> Fusion in Hepatoblastoma. Comment on "Fleifil et al. DNAJB1-PKAc Kinase Is Expressed in Young Patients with Pediatric Liver Cancers and Enhances Carcinogenic Pathways. <i>Cancers</i> 2025, <i>17</i>, 83"Yasmeen Fleifil, Ruhi Gulati, Katherine Jennings, et al.
Molecular and Cellular Biology|August 7, 2019
Correction of Glycogen Synthase Kinase 3β in Myotonic Dystrophy 1 Reduces the Mutant RNA and Improves Postnatal Survival of DMSXL MiceMei Wang, Wen-Chin Weng, Lauren Stock, et al.
International Journal of Molecular Sciences|November 13, 2025
Elevated Levels of Active GSK3β in the Blood of Patients with Myotonic Dystrophy Type 1 Correlate with Muscle WeaknessKatherine Jennings, Cuixia Tian, Rebeccah L Brown, et al.
The EMBO Journal|January 17, 2004
Competition of CUGBP1 and calreticulin for the regulation of p21 translation determines cell fatePolina Iakova, Guo-Li Wang, Lubov Timchenko, et al.
The Journal of Biological Chemistry|April 9, 2013
Transcriptional and translational regulation of C/EBPβ-HDAC1 protein complexes controls different levels of p53, SIRT1, and PGC1α proteins at the early and late stages of liver cancerJingling Jin, Polina Iakova, Yanjun Jiang, et al.
Molecular and Cellular Biology|June 1, 2017
RNA Binding Protein CUGBP1 Inhibits Liver Cancer in a Phosphorylation-Dependent MannerKyle Lewis, Leila Valanejad, Ashley Cast, et al.
Pageof 5